TY - JOUR
T1 - Interpretation of clinical trial results
T2 - a committee opinion
AU - Practice Committee of the American Society for Reproductive Medicine
AU - Penzias, Alan
AU - Bendikson, Kristin
AU - Butts, Samantha
AU - Falcone, Tommaso
AU - Gitlin, Susan
AU - Gracia, Clarisa
AU - Hansen, Karl
AU - Hill, Micah
AU - Hurd, William
AU - Jindal, Sangita
AU - Kalra, Suleena
AU - Mersereau, Jennifer
AU - Odem, Randall
AU - Rebar, Robert
AU - Reindollar, Richard
AU - Rosen, Mitchell
AU - Sandlow, Jay
AU - Schlegel, Peter
AU - Steiner, Anne
AU - Tanrikut, Cigdem
AU - Stovall, Dale
N1 - Funding Information:
This report was developed under the direction of the Practice Committee of the American Society for Reproductive Medicine as a service to its members and other practicing clinicians. Although this document reflects appropriate management of a problem encountered in the practice of reproductive medicine, it is not intended to be the only approved standard of practice or to dictate an exclusive course of treatment. Other plans of management may be appropriate, considering the needs of the individual patient, available resources, and institutional or clinical practice limitations. The Practice Committee and the Board of Directors of the American Society for Reproductive Medicine have approved this report. This document was reviewed by ASRM members and their input was considered in the preparation of the final document. The following members of the ASRM Practice Committee participated in the development of this document. All Committee members disclosed commercial and financial relationships with manufacturers or distributors of goods or services used to treat patients. Members of the Committee who were found to have conflicts of interest based on the relationships disclosed did not participate in the discussion or development of this document. Alan Penzias, M.D.; Kristin Bendikson, M.D.; Samantha Butts, M.D. M.S.C.E.; Tommaso Falcone, M.D.; Susan Gitlin, Ph.D.; Clarisa Gracia, M.D. M.S.C.E; Karl Hansen, M.D. Ph.D.; Micah Hill, D.O.; William Hurd, M.D. M.P.H.; Sangita Jindal, Ph.D.; Suleena Kalra, M.D. M.S.C.E.; Jennifer Mersereau, M.D.; Randall Odem, M.D.; Robert Rebar, M.D.; Richard Reindollar, M.D.; Mitchell Rosen, M.D.; Jay Sandlow, M.D.; Peter Schlegel, M.D.; Anne Steiner, M.D. M.P.H.; Cigdem Tanrikut, M.D.; and Dale Stovall, M.D.
Publisher Copyright:
© 2019 American Society for Reproductive Medicine
PY - 2020/2
Y1 - 2020/2
N2 - This document provides guidance, background, and tips on how to recognize quality trials and focuses on evaluating the validity, importance, and relevance of clinical trial results. This document replaces the document of the same name, last published in 2008 (Fertil Steril® 2008;90:S114–20).
AB - This document provides guidance, background, and tips on how to recognize quality trials and focuses on evaluating the validity, importance, and relevance of clinical trial results. This document replaces the document of the same name, last published in 2008 (Fertil Steril® 2008;90:S114–20).
UR - http://www.scopus.com/inward/record.url?scp=85079881322&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079881322&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2019.11.009
DO - 10.1016/j.fertnstert.2019.11.009
M3 - Article
C2 - 32106975
AN - SCOPUS:85079881322
SN - 0015-0282
VL - 113
SP - 295
EP - 304
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 2
ER -